Cargando…
Glycemic Control in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
Background: Given the mortality risk in COVID-19 patients, it is necessary to estimate the impact of glycemic control on mortality rates among inpatients by designing and implementing evidence-based blood glucose (BG) control methods. There is evidence to suggest that COVID-19 patients with hypergly...
Autores principales: | Chander, Subhash, Deepak, Vishal, Kumari, Roopa, Leys, Lorenzo, Wang, Hong Yu, Mehta, Puja, Sadarat, FNU |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094858/ https://www.ncbi.nlm.nih.gov/pubmed/37048638 http://dx.doi.org/10.3390/jcm12072555 |
Ejemplares similares
-
Gender and racial differences in first and senior authorship of high-impact critical care randomized controlled trial studies from 2000 to 2022
por: Chander, Subhash, et al.
Publicado: (2023) -
Glycemic variability and outcome in critically ill
por: Todi, Subhash, et al.
Publicado: (2014) -
Glycemic control in critically ill: A moving target
por: Todi, Subhash
Publicado: (2014) -
Chronic hyperglycemia in critically ill: Another piece in the glycemic control puzzle
por: Todi, Subhash
Publicado: (2014) -
Diagnosis of ventilator-associated pneumonia in critically ill adult patients—a systematic review and meta-analysis
por: Fernando, Shannon M., et al.
Publicado: (2020)